Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS-CoV-2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir.

tanespimycin (BMS-722782) - BMS

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42599674

Anindita Chakrabarty; Anshuman Chandra; Gargi Mukherjee; Goutam Chowdhury; Shayantani Chakraborty

Aug 15, 2026